A total of 37 participants with type 2 diabetes (20 male and 17 female, aged 70.2 ± 10.0 years with BMI 31.0 (28.0-34.0) kg/m2 and duration of diabetes for 15.2 ± 7.7 years) were switched from premixed insulin treatment to iDegLira. This evidence concerns the gene INS and diabetes mellitus.